What is the Parmax Pharma Ltd share price today?

The share price of BSE:PARMAX-XT on 21 Sep 2026 (as of 10:24:14 IST) is ₹136.4.

What is the BSE:PARMAX-XT 52 week high low price?

Over the past 52 weeks (as of 21 Sep 2026), the BSE:PARMAX-XT 52 week high low range shows a high of ₹136.4 and a low of ₹22.6.

What is the Parmax Pharma Ltd market cap?

As on 21 Sep 2026, Parmax Pharma Ltd market cap is ₹928994000.

What is the shareholding pattern of Parmax Pharma Ltd Stock?

The shareholding pattern of Parmax Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 30.8% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 69.2% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Parmax Pharma Ltd?

The Price-to-Earnings (PE) ratio of Parmax Pharma Ltd is 0, and the Price-to-Book (PB) ratio is -5.8563, as on 21 Sep 2026.

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+0.98%

1 Week

+0.98%

1 Month

+4.00%

3 Month

+52.06%

6 Month

+353.83%

YTD

+311.17%

1 Year

+309.24%

5 Year

+223.49%

10 Year

NA

Max

+666.39%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

136.40

135.00

93.30

27.45

22.60

High

139.10

About

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

No results found

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

Financial overview

Peer Comparison

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Balance Sheet

Consolidated

Standalone

₹

%

Cash Flow

Consolidated

Standalone

₹

%

Fundamental Ratios

Consolidated

Standalone

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

Shareholding summary

No data available

Promoters

—

FII

—

DII

—

MF

—

Others

—

Promoters

FII

DII

MF

Others

Quarterly

Yearly

No data available

Shareholding Pattern

Quarterly

Yearly

No results found

Bulk & block deals

No results found

Insider trading & SAST

No results found

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

Registrars

Management

Details

BSE

NSE

ISIN

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

Corporate filings & documents

No corporate filings & documents found

Parmax Pharma Share Price

139.10+1.35 (+0.98%)

+309.24% past 1 Year

News

SML Mahindra September Sales Rise Eighteen Percent On Commercial Vehicle Demand

Equity

SMLMAH

8 Oct 2026

MRPL Board To Discuss Interim Dividend For Financial Year 2026 27

Equity

MRPL

8 Oct 2026

Vishnu Chemicals To Meet Analysts And Investors On October 14

Equity

VISHNU

8 Oct 2026

IKIO Technologies Subsidiary Signs Exclusive Deal With Danube Home

Equity

IKIO

8 Oct 2026

Maharashtra GST Officials Search Pitti Engineering Manufacturing Unit Under Section 67

Equity

PITTIENG

8 Oct 2026

Titan redeems commercial papers worth Rs 825 crores with payments to investors

Equity

TITAN

8 Oct 2026

Brent Crude Trades Above 105 Dollars Amid Middle East Supply Disruptions

Commodity

8 Oct 2026

JSW Steel Reports Ten Percent Quarterly Growth In Crude Steel Production

Equity

JSWSTEEL

8 Oct 2026

Dr Reddy's FTO 11 Facility Receives USFDA Form 483 Observations

Equity

8 Oct 2026

Shakti Pumps Invests Rs 10 Crores In Subsidiary Solar Manufacturing Plant

Equity

SHAKTIPUMP

8 Oct 2026

TCS Declares Interim Dividend Of Rs 12 Per Share

Equity

TCS

8 Oct 2026

TCS Q2 EBIT Rises Marginally, Margin Nearly Flat Sequentially

Equity

TCS

8 Oct 2026

TCS Reports Second Quarter Revenue Growth Quarter On Quarter

Equity

TCS

8 Oct 2026

TCS Reports Annual AI Revenue Of 310 Crores In Q2 FY27

Equity

TCS

8 Oct 2026

TCS Second Quarter Consolidated Profit Exceeds Analyst Estimate

Equity

TCS

8 Oct 2026

Nifty Ends Sharply Lower Amid Broad Based Market Weakness

Broader Market

8 Oct 2026

GST Discussions Focus On Filing Ease As Markets Face Broad Midday Selling

Broader Market

8 Oct 2026

NCL Industries reports higher cement output and dispatches in second quarter

Equity

NCLIND

8 Oct 2026

Piccadily Agro launches limited edition Indri whisky with international awards

Equity

PICCADIL

8 Oct 2026

Aye Finance Reports Strong AUM Growth And Improved Gross NPA

Equity

AYE

8 Oct 2026

Parmax Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Parmax Pharma Share Price

Parmax Pharma Share Price

Financial overview

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Parmax Pharma Share Price

Parmax Pharma Share Price

Parmax Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Parmax Pharma Share Price

Corporate Actions

Company details

Parmax Pharma Share Price

Corporate filings & documents

Parmax Pharma Share Price

News

SML Mahindra September Sales Rise Eighteen Percent On Commercial Vehicle Demand

MRPL Board To Discuss Interim Dividend For Financial Year 2026 27

Vishnu Chemicals To Meet Analysts And Investors On October 14

IKIO Technologies Subsidiary Signs Exclusive Deal With Danube Home

Maharashtra GST Officials Search Pitti Engineering Manufacturing Unit Under Section 67

Titan redeems commercial papers worth Rs 825 crores with payments to investors

Brent Crude Trades Above 105 Dollars Amid Middle East Supply Disruptions

JSW Steel Reports Ten Percent Quarterly Growth In Crude Steel Production

Dr Reddy's FTO 11 Facility Receives USFDA Form 483 Observations

Shakti Pumps Invests Rs 10 Crores In Subsidiary Solar Manufacturing Plant

TCS Declares Interim Dividend Of Rs 12 Per Share

TCS Q2 EBIT Rises Marginally, Margin Nearly Flat Sequentially

TCS Reports Second Quarter Revenue Growth Quarter On Quarter

TCS Reports Annual AI Revenue Of 310 Crores In Q2 FY27

TCS Second Quarter Consolidated Profit Exceeds Analyst Estimate

Nifty Ends Sharply Lower Amid Broad Based Market Weakness

GST Discussions Focus On Filing Ease As Markets Face Broad Midday Selling

NCL Industries reports higher cement output and dispatches in second quarter

Piccadily Agro launches limited edition Indri whisky with international awards

Aye Finance Reports Strong AUM Growth And Improved Gross NPA

Parmax Pharma Ltd Share Price Today

Parmax Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator